Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia

Head Neck. 2012 Dec;34(12):1681-703. doi: 10.1002/hed.23136. Epub 2012 Sep 26.

Abstract

Recent advances now permit resection of many pharyngeal tumors through the open mouth, an approach that can greatly reduce the morbidity of surgical exposure. These transoral techniques are being rapidly adopted by the surgical community and hold considerable promise. On November 6-7, 2011, the National Cancer Institute sponsored a Clinical Trials Planning Meeting to address how to further investigate the use of transoral surgery, both in the good prognosis human papillomavirus (HPV)-initiated oropharyngeal cancers, and in those with HPV-unrelated disease. The proceedings of this meeting are summarized.

MeSH terms

  • Clinical Trials as Topic*
  • Combined Modality Therapy
  • Comorbidity
  • Congresses as Topic
  • Cost-Benefit Analysis
  • Head and Neck Neoplasms / economics
  • Head and Neck Neoplasms / epidemiology
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / therapy
  • Head and Neck Neoplasms / virology
  • Humans
  • Microsurgery
  • Neoplasm Recurrence, Local
  • Oropharyngeal Neoplasms / pathology
  • Oropharyngeal Neoplasms / prevention & control
  • Oropharyngeal Neoplasms / surgery
  • Oropharyngeal Neoplasms / therapy
  • Papillomavirus Infections / complications
  • Pharyngeal Neoplasms / pathology
  • Pharyngeal Neoplasms / prevention & control
  • Pharyngeal Neoplasms / surgery*
  • Pharyngeal Neoplasms / therapy
  • Quality of Life
  • Research Design
  • Robotics
  • Treatment Outcome